货号:A997327
同义名:
Tricyclodecan-9-yl xanthogenate; D609 (potassium salt)
D609是一种竞争性磷脂酰胆碱特异性磷脂酶 C(PC-PLC)抑制剂,Ki 为 6.4 μM。它具有抗病毒和抗肿瘤作用,也能作为抗氧化保护剂。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | D609 is a selective competitive phosphatidyl choline-specific phospholipase C (PC-PLC) inhibitor (Ki = 6.4 μM) and antiviral and antitumor agent. |
Concentration | Treated Time | Description | References | |
neonatal rat ventricular myocytes | 100 μM | 12 h | Inhibits phospholipase C, preventing hypoxia-induced redistribution of PKCα and PKCε | J Clin Invest. 1997 Jan 1;99(1):55-61 |
SKOV3 cells | 53 μg/mL | 24 h | Inhibition of PC-plc activity, resulting in a 44% reduction of PCho content | Cancer Res. 2010 Mar 1;70(5):2126-35 |
OVCAR3 cells | 53 μg/mL | 24 h | Inhibition of PC-plc activity, resulting in a 30-40% reduction of PCho content and blocking cell proliferation | Cancer Res. 2010 Mar 1;70(5):2126-35 |
human aorta smooth muscle cells (HASMCs) | 100 μM | 30 min | inhibited IL-1β-induced MCP1 expression by blocking NF-κB translocation to the nucleus | Exp Mol Med. 2009 Oct 31;41(10):757-64 |
A549 cells | 350 μM | 16 h | Inhibited SMS activity, reversing the increase in SM levels induced by 2OHOA | Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19569-74 |
microglia | 10 μM | 60 min | D609 inhibits PC-PLC activity, blocking TNFα-induced PARP-1 activation and NF-κB transcriptional activation | J Neuroinflammation. 2015 Dec 4;12:229 |
mouse cortical astrocytes | 10 μM | 60 min | D609 inhibits PC-PLC activity, blocking TNFα-induced PARP-1 activation and NF-κB transcriptional activation | J Neuroinflammation. 2015 Dec 4;12:229 |
Adult human RPE cells (hRPE) | 10 μM | 12-24 h | D609 maintained hRPE cell morphology and expression of ZO-1 and MITF, preventing oxidative damage | Signal Transduct Target Ther. 2020 Mar 4;5(1):20 |
Human fetal RPE cells (ftRPE) | 10 μM | 18-24 h | D609 significantly enhanced the survival rate of ftRPE cells under severe oxidative stress and reduced the number of necrotic and apoptotic cells | Signal Transduct Target Ther. 2020 Mar 4;5(1):20 |
ARPE-19 cells | 10 μM | 24 h | D609 strongly protected ARPE-19 cells from SI-induced oxidative cell death and maintained normal cellular morphology | Signal Transduct Target Ther. 2020 Mar 4;5(1):20 |
Administration | Dosage | Frequency | Description | References | ||
Mongolian gerbils | Alzheimer's disease-related oxidative stress model | Intraperitoneal injection | 50 mg/kg | Single injection, sampled after 1 hour | D609 treatment significantly reduced oxidative stress-induced protein carbonyls, HNE-bound proteins, 3-NT levels, and cytochrome c release, and maintained the GSH/GSSG ratio. | Free Radic Biol Med. 2006 Dec 1;41(11):1694-703 |
C57BL/6 mice | SI-induced AMD mouse model | Orbital venous plexus injection | 25 mg/kg | Single injection, observed up to 7 days post-injection | D609 significantly protected the RPE layer from SI-induced damage and maintained retinal physiological function | Signal Transduct Target Ther. 2020 Mar 4;5(1):20 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00669734 | Pancreatic Acinar Cell Carcino... 展开 >>ma Pancreatic Ductal Adenocarcinoma Stage III Pancreatic Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer AJCC v6 and v7 收起 << | Phase 1 | Active, not recruiting | - | United States, New Jersey ... 展开 >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.75mL 0.75mL 0.38mL |
18.76mL 3.75mL 1.88mL |
37.53mL 7.51mL 3.75mL |
CAS号 | 83373-60-8 |
分子式 | C11H15KOS2 |
分子量 | 266.46 |
SMILES Code | [S-]C(OC1C(C2)C3CCCC3C2C1)=S.[K+] |
MDL No. | MFCD00171401 |
别名 | Tricyclodecan-9-yl xanthogenate; D609 (potassium salt); D-609 free |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
DMSO: 105 mg/mL(394.05 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 2 mg/mL(7.51 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|